Amyotrophic lateral sclerosis

被引:514
作者
Mitchell, J. D. [1 ]
Borasio, G. D.
机构
[1] Royal Preston Hosp, Motor Neurone Dis Care & Res Ctr, Preston PR2 9HT, Lancs, England
[2] Munich Univ Hosp, Dept Neurol, Interdisciplinary Ctr Palliat Med, D-81366 Munich, Germany
[3] Munich Univ Hosp, Dept Neurol, Motor Neurone Dis Res Grp, D-81366 Munich, Germany
关键词
D O I
10.1016/S0140-6736(07)60944-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amyotrophic lateral sclerosis (known in the UK as motor neuron disease) is a devastating illness with uncertain pathogenesis. In this Seminar, we review its natural history, clinical features, diagnostic criteria, variant and mimic syndromes, genetic forms, and epidemiology. Several hypotheses about causes of the disorder are discussed, such as excitotoxicity and oxidant stress, and we review past and present putative disease-modifying treatments. Disease-management strategies, from telling the patient about their illness to end-of-life decisions and palliative care, are presented. We review options for control of the main symptoms of amyotrophic lateral sclerosis-including dysphagia, dysarthria, respiratory distress, pain, and psychological disorders-and care in the terminal phase. The need for good psychosocial and spiritual care of patients and families is emphasised. We conclude with an overview of some current major issues and future prospects, ranging from the search for disease markers to challenging developments such as stem-cell and gene therapy.
引用
收藏
页码:2031 / 2041
页数:11
相关论文
共 117 条
[21]  
Brooks BR, 2004, NEUROLOGY, V63, P1364
[23]  
Brooks BR, 1996, ARCH NEUROL-CHICAGO, V53, P141
[24]   Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation [J].
Ceroni, M ;
Malaspina, A ;
Poloni, TE ;
Alimonti, D ;
Rognoni, F ;
Habgood, J ;
Imbesi, F ;
Antonelli, P ;
Alfonsi, E ;
Curti, D ;
deBelleroche, J .
NEUROLOGY, 1999, 53 (05) :1064-1071
[25]   Axonal transport and neurodegenerative disease [J].
Chevalier-Larsen, Erica ;
Holzbaur, Erika L. F. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (11-12) :1094-1108
[26]   Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players [J].
Chiò, A ;
Benzi, G ;
Dossena, M ;
Mutani, R ;
Mora, G .
BRAIN, 2005, 128 :472-476
[27]   Percutaneous radiological gastrostomy:: a safe and effective method of nutritional tube placement in advanced ALS [J].
Chiò, A ;
Galletti, R ;
Finocchiaro, C ;
Righi, D ;
Ruffino, MA ;
Calvo, A ;
Di Vito, N ;
Ghiglione, P ;
Terreni, AA ;
Mutani, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (04) :645-647
[28]   A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis [J].
Cudkowicz, ME ;
Shefner, JM ;
Schoenfeld, DA ;
Brown, RH ;
Johnson, H ;
Qureshi, M ;
Jacobs, M ;
Rothstein, JD ;
Appel, SH ;
Pascuzzi, RM ;
Heiman-Patterson, TD ;
Donofrio, PD ;
David, WS ;
Russell, JA ;
Tandan, R ;
Pioro, EP ;
Felice, KJ ;
Rosenfeld, J ;
Mandler, RN ;
Sachs, GM ;
Bradley, WG ;
Raynor, EM ;
Baquis, GD ;
Belsh, JM ;
Novella, S ;
Goldstein, J ;
Hulihan, J .
NEUROLOGY, 2003, 61 (04) :456-464
[29]   Neurophysiological measures in amyotrophic lateral sclerosis: Markers of progression in clinical trials [J].
de Carvalho, M ;
Chio, A ;
Dengler, R ;
Hecht, M ;
Weber, M ;
Swash, M .
AMYOTROPHIC LATERAL SCLEROSIS, 2005, 6 (01) :17-28
[30]  
de Paulis Tomas, 2003, Curr Opin Investig Drugs, V4, P863